10.04.2013
- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said...
10.04.2013
- Thermo Fisher Scientific made a binding offer for Life Technologies on Tuesday as private equity firms raced to finalize a consortium to take the genetic testing equipment maker...
09.04.2013
- Sirion Biotech has won two additional private investors, one of them being Aumenta. Both contribute to a large extent to the current financing round side by side with the existing...
04.04.2013
- A number of U.S. farm groups want to extend a law that allows farmers to grow a genetically modified crop while regulatory approval of the variety is still being challenged in...
03.04.2013
- AstraZeneca boosted its early-stage pipeline of experimental heart drugs on Wednesday by buying privately held U.S. biotechnology company AlphaCore Pharma, which is developing a...
27.03.2013
- Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...
26.03.2013
- Monsanto and DuPont have settled a bitter legal battle over rights to technology for genetically modified seeds and will drop antitrust and patent claims against each other while...
25.03.2013
- Shire is to buy privately owned U.S. biotech firm SARcode Bioscience, paying $160 million upfront to win rights to a new drug in late-stage development for dry eye diseases. The...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
22.03.2013
- Monsanto hopes to roll out a new bioengineered, worm-resistant soybean seed for planting in Brazil next season, the firm's local president said, but a successful launch is tied to...
